Sumitomo Mitsui Trust Group
GBT

Sumitomo Mitsui Trust Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,218
Closed -$253K – 1222
2021
Q2 		$253K Sell
7,218
-465
-6% -$18.2K ﹤0.01% 1157
2021
Q1 		$313K Sell
7,683
-227
-3% -$10.4K ﹤0.01% 1114
2020
Q4 		$343K Buy
7,910
+585
+8% +$28.8K ﹤0.01% 1089
2020
Q3 		$404K Hold
7,325
– – ﹤0.01% 1049
2020
Q2 		$462K Sell
7,325
-487
-6% -$33.4K ﹤0.01% 1027
2020
Q1 		$399K Buy
+7,812
New +$523K ﹤0.01% 1020

Other funds holding GBT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group's GBT Position: Q3 2021 in Review

Sumitomo Mitsui Trust Group sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2021, closing a stake of 7,218 shares — an estimated $253K sold.

Sumitomo Mitsui Trust Group first reported a position in GBT in Q1 2020 and held it in 6 quarters. The position peaked at $462K in Q2 2020. 187 funds tracked by Wall St. Rank hold GBT as of Q3 2021.

  • Sumitomo Mitsui Trust Group reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2021 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 7,218 Global Blood Therapeutics, Inc. shares in Q3 2021, an estimated $253K.
  • Sumitomo Mitsui Trust Group first reported a position in Global Blood Therapeutics, Inc. in Q1 2020 and held it in 6 quarters.
  • Sumitomo Mitsui Trust Group's Global Blood Therapeutics, Inc. position peaked at $462K in Q2 2020.
  • 187 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2021.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q3 2021, filed 25 Oct 2021.